|
HY-N1677-100mg
|
MedChemexpress LLC
|
2,6-Dimethoxy-1,4-benzoquinone [CAS 530-55-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-N1677-50mg
|
MedChemexpress LLC
|
2,6-Dimethoxy-1,4-benzoquinone [CAS 530-55-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P1005-1mg
|
MedChemexpress LLC
|
Ac-DEVD-AFC [CAS 201608-14-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P1005-10mg
|
MedChemexpress LLC
|
Ac-DEVD-AFC [CAS 201608-14-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P1005-5mg
|
MedChemexpress LLC
|
Ac-DEVD-AFC [CAS 201608-14-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101879-100mg
|
MedChemexpress LLC
|
Acridine Orange (hydrochloride) [CAS 65-61-2]
|
|
|
|
|
HY-101879-1mL
|
MedChemexpress LLC
|
Acridine Orange (hydrochloride) [CAS 65-61-2] (10mM in DMSO)
|
|
|
|
|
HY-101880-1mg
|
MedChemexpress LLC
|
ADHP [CAS 119171-73-2]
|
|
|
|
|
HY-101880-5mg
|
MedChemexpress LLC
|
ADHP [CAS 119171-73-2]
|
|
|
|
|
HY-100320-1mg
|
MedChemexpress LLC
|
AVE5688 [CAS 613260-13-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-B1599-1mg
|
MedChemexpress LLC
|
Chloramphenicol palmitate [CAS 530-43-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1599-10mg
|
MedChemexpress LLC
|
Chloramphenicol palmitate [CAS 530-43-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1599-25mg
|
MedChemexpress LLC
|
Chloramphenicol palmitate [CAS 530-43-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1599-5mg
|
MedChemexpress LLC
|
Chloramphenicol palmitate [CAS 530-43-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1599-1mL
|
MedChemexpress LLC
|
Chloramphenicol palmitate [CAS 530-43-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-D1713-50ug
|
MedChemexpress LLC
|
CM-H2DCFDA [CAS 850013-49-9]
|
|
|
|
|
HY-N7476-10mg
|
MedChemexpress LLC
|
Colominic acid (sodium salt) [CAS 70431-34-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N7476-5mg
|
MedChemexpress LLC
|
Colominic acid (sodium salt) [CAS 70431-34-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3735-1mg
|
MedChemexpress LLC
|
Deoxyvasicinone [CAS 530-53-0]
|
|
|
|
|
HY-N3735-10mg
|
MedChemexpress LLC
|
Deoxyvasicinone [CAS 530-53-0]
|
|
|
|
|
HY-N3735-5mg
|
MedChemexpress LLC
|
Deoxyvasicinone [CAS 530-53-0]
|
|
|
|
|
HY-B1221-100mg
|
MedChemexpress LLC
|
Flufenamic acid [CAS 530-78-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1221-1mL
|
MedChemexpress LLC
|
Flufenamic acid [CAS 530-78-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-130027-1mg
|
MedChemexpress LLC
|
HKOCl-4 [CAS 2031170-85-9]
|
|
|
|
|
HY-107558-1mg
|
MedChemexpress LLC
|
JNJ10191584 (maleate) [CAS 869497-75-6]
|
|
Neuroscience-Neuromodulation
|
|
